These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

833 related items for PubMed ID: 11519776

  • 1. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
    Caro JJ, Salas M, Ward A.
    Clin Ther; 2001 Jul; 23(7):998-1017. PubMed ID: 11519776
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
    Welage LS, Berardi RR.
    J Am Pharm Assoc (Wash); 2000 Jul; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
    [Abstract] [Full Text] [Related]

  • 3. Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials.
    Salas M, Ward A, Caro J.
    BMC Gastroenterol; 2002 Jul 15; 2():17. PubMed ID: 12119060
    [Abstract] [Full Text] [Related]

  • 4. Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients.
    Pilotto A, Franceschi M, Leandro G, Scarcelli C, D'Ambrosio LP, Paris F, Annese V, Seripa D, Andriulli A, Di Mario F.
    World J Gastroenterol; 2007 Sep 07; 13(33):4467-72. PubMed ID: 17724802
    [Abstract] [Full Text] [Related]

  • 5. Are the orally administered proton pump inhibitors equivalent? A comparison of lansoprazole, omeprazole, pantoprazole, and rabeprazole.
    Thomson AB.
    Curr Gastroenterol Rep; 2000 Dec 07; 2(6):482-93. PubMed ID: 11079051
    [Abstract] [Full Text] [Related]

  • 6. A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.
    Jaspersen D, Diehl KL, Schoeppner H, Geyer P, Martens E.
    Aliment Pharmacol Ther; 1998 Jan 07; 12(1):49-52. PubMed ID: 9692700
    [Abstract] [Full Text] [Related]

  • 7. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
    Fitton A, Wiseman L.
    Drugs; 1996 Mar 07; 51(3):460-82. PubMed ID: 8882382
    [Abstract] [Full Text] [Related]

  • 8. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.
    Röhss K, Lind T, Wilder-Smith C.
    Eur J Clin Pharmacol; 2004 Oct 07; 60(8):531-9. PubMed ID: 15349707
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
    van Zyl J, van Rensburg C, Vieweg W, Fischer R.
    Digestion; 2004 Oct 07; 70(1):61-9. PubMed ID: 15297779
    [Abstract] [Full Text] [Related]

  • 10. Rabeprazole: a review of its use in acid-related gastrointestinal disorders.
    Langtry HD, Markham A.
    Drugs; 1999 Oct 07; 58(4):725-42. PubMed ID: 10551440
    [Abstract] [Full Text] [Related]

  • 11. Symptom relief in patients with reflux esophagitis: comparative study of omeprazole, lansoprazole, and rabeprazole.
    Adachi K, Hashimoto T, Hamamoto N, Hirakawa K, Niigaki M, Miyake T, Taniura H, Ono M, Kaji T, Suetsugu H, Yagi J, Komazawa Y, Mihara T, Katsube T, Fujishiro H, Shizuku T, Hattori S, Yamamoto S, Kinoshita Y.
    J Gastroenterol Hepatol; 2003 Dec 07; 18(12):1392-8. PubMed ID: 14675268
    [Abstract] [Full Text] [Related]

  • 12. Prevention of erosive oesophagitis relapse with pantoprazole.
    Richter JE, Fraga P, Mack M, Sabesin SM, Bochenek W, Pantoprazole US GERD Study Group.
    Aliment Pharmacol Ther; 2004 Sep 01; 20(5):567-75. PubMed ID: 15339328
    [Abstract] [Full Text] [Related]

  • 13. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.
    Miner P, Katz PO, Chen Y, Sostek M.
    Am J Gastroenterol; 2003 Dec 01; 98(12):2616-20. PubMed ID: 14687806
    [Abstract] [Full Text] [Related]

  • 14. Rabeprazole: an update of its use in acid-related disorders.
    Carswell CI, Goa KL.
    Drugs; 2001 Dec 01; 61(15):2327-56. PubMed ID: 11772142
    [Abstract] [Full Text] [Related]

  • 15. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
    Cheer SM, Prakash A, Faulds D, Lamb HM.
    Drugs; 2003 Dec 01; 63(1):101-33. PubMed ID: 12487624
    [Abstract] [Full Text] [Related]

  • 16. Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis.
    Zheng RN.
    World J Gastroenterol; 2009 Feb 28; 15(8):990-5. PubMed ID: 19248200
    [Abstract] [Full Text] [Related]

  • 17. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D, Paré P, Pericak D, Pyzyk M, Canadian Pantoprazole GERD Study Group.
    Am J Gastroenterol; 2001 Oct 28; 96(10):2849-57. PubMed ID: 11695354
    [Abstract] [Full Text] [Related]

  • 18. Cost-effectiveness comparison of current proton-pump inhibitors to treat gastro-oesophageal reflux disease in the UK.
    Remák E, Brown RE, Yuen C, Robinson A.
    Curr Med Res Opin; 2005 Oct 28; 21(10):1505-17. PubMed ID: 16238890
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of rabeprazole once daily for acid-related disorders.
    Lanza F, Bardhan KD, Perdomo C, Niecestro R, Barth J.
    Dig Dis Sci; 2001 Mar 28; 46(3):587-96. PubMed ID: 11318537
    [Abstract] [Full Text] [Related]

  • 20. An overview of proton pump inhibitors.
    Der G.
    Gastroenterol Nurs; 2003 Mar 28; 26(5):182-90. PubMed ID: 14603076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.